R. Loch Macdonald

2018

In 2018, R. Loch Macdonald earned a total compensation of $443K as Chief Scientific Officer at Edge Therapeutics, a 66% decrease compared to previous year.

Compensation breakdown

Option Awards$11,578
Salary$150,750
Stock Awards$8,510
Other$272,179
Total$443,017

Macdonald received $272.2K in other compensation, accounting for 61% of the total pay in 2018.

Macdonald also received $11.6K in option awards, $150.8K in salary and $8.5K in stock awards.

Rankings

In 2018, R. Loch Macdonald's compensation ranked 12,247th out of 14,244 executives tracked by ExecPay. In other words, Macdonald earned more than 14.0% of executives.

ClassificationRankingPercentile
All
12,247
out of 14,244
14th
Division
Manufacturing
4,955
out of 5,759
14th
Major group
Chemicals And Allied Products
1,871
out of 2,122
12th
Industry group
Drugs
1,600
out of 1,811
12th
Industry
Pharmaceutical Preparations
1,226
out of 1,385
12th
Source: SEC filing on August 15, 2019.

Macdonald's colleagues

We found four more compensation records of executives who worked with R. Loch Macdonald at Edge Therapeutics in 2018.

2018

Brian Leuthner

Edge Therapeutics

Chief Executive Officer

2018

W Middlekauff

Edge Therapeutics

General Counsel

2018

Herbert Faleck

Edge Therapeutics

Chief Medical Officer

2018

Andrew Saik

Edge Therapeutics

Chief Financial Officer

News

You may also like